Charles Schwab Investment Management Inc. Has $16.30 Million Position in Pediatrix Medical Group, Inc. $MD

Key Points

• Charles Schwab Investment Management Inc. reduced its stake in Pediatrix Medical Group by 2.9%, selling 33,288 shares and holding approximately 1.31% of the company worth $16.3 million as of the end of the last quarter.
• Pediatrix Medical Group reported earnings per share of $0.53 for the last quarter, surpassing the consensus estimate of $0.42, despite a 7.1% decline in revenue compared to the same quarter last year.
• Institutional investors own 97.71% of Pediatrix Medical Group's stock, with several firms increasing their holdings significantly during the first quarter of the year.

Charles Schwab Investment Management Inc. decreased its holdings in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 2.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,124,952 shares of the company's stock after selling 33,288 shares during the quarter. Charles Schwab Investment Management Inc. owned 1.31% of Pediatrix Medical Group worth $16,301,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently made changes to their positions in MD. GAMMA Investing LLC raised its stake in shares of Pediatrix Medical Group by 219.5% in the 1st quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock valued at $37,000 after buying an additional 1,765 shares in the last quarter. Tower Research Capital LLC TRC grew its holdings in shares of Pediatrix Medical Group by 218.0% in the 4th quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company's stock worth $98,000 after purchasing an additional 5,104 shares during the last quarter. Squarepoint Ops LLC bought a new stake in shares of Pediatrix Medical Group in the 4th quarter worth about $132,000. Sherbrooke Park Advisers LLC bought a new stake in shares of Pediatrix Medical Group in the 4th quarter worth about $136,000. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management bought a new stake in shares of Pediatrix Medical Group in the 1st quarter worth about $159,000. Institutional investors and hedge funds own 97.71% of the company's stock.

Pediatrix Medical Group Price Performance

MD traded down $0.04 during midday trading on Thursday, hitting $17.15. The company had a trading volume of 810,279 shares, compared to its average volume of 937,691. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.80 and a current ratio of 1.80. The company has a market capitalization of $1.49 billion, a PE ratio of 13.29 and a beta of 1.21. Pediatrix Medical Group, Inc. has a twelve month low of $10.06 and a twelve month high of $17.67. The firm's 50-day simple moving average is $14.05 and its 200-day simple moving average is $14.02.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.53 earnings per share for the quarter, beating the consensus estimate of $0.42 by $0.11. The firm had revenue of $468.84 million during the quarter, compared to analysts' expectations of $464.37 million. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The company's quarterly revenue was down 7.1% compared to the same quarter last year. During the same quarter last year, the company posted $0.34 EPS. Equities research analysts predict that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

MD has been the topic of several analyst reports. Macquarie upped their target price on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an "outperform" rating in a report on Thursday, May 8th. UBS Group upped their target price on shares of Pediatrix Medical Group from $16.00 to $16.50 and gave the stock a "neutral" rating in a report on Thursday, August 14th. Finally, Zacks Research raised shares of Pediatrix Medical Group to a "strong-buy" rating in a report on Monday, August 11th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $16.75.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.